How Can a Pharmacy Support a Prescribed Digital Therapeutic?
As healthcare continues its shift toward more personalized, technology-enabled care, digital therapeutics are emerging as an important new category of treatment.
Digital therapeutics (DTx) are software-based therapies — typically FDA-authorized through pathways such as De Novo or 510(k) — designed to prevent, manage, or treat medical conditions using evidence-based clinical interventions delivered through digital platforms. This distinguishes them from general wellness apps or broader digital health tools: DTx products carry a clinical evidence bar and regulatory standing that makes them appropriate for prescription. These tools may be prescribed by healthcare providers and accessed through smartphones, tablets, or computers, allowing patients to engage with their treatment in ways that were not possible just a few years ago.
But prescribing a digital therapeutic is only the beginning of the patient journey.
Just like traditional medications, digital therapeutics require the right infrastructure to ensure patients can access, activate, and successfully use the therapy. This is where pharmacies play a critical role. As digital health adoption accelerates, pharmacies are increasingly becoming the operational backbone that helps translate a prescription into a real therapeutic experience for the patient.
The Expanding Role of Pharmacies in Digital Therapeutics
Pharmacies support digital therapeutics across several important stages of the treatment journey. From prescription verification to patient education and reimbursement, the pharmacy helps ensure these innovative therapies reach patients efficiently and effectively.
Verifying the Prescription
Pharmacists are responsible for verifying that the prescribed digital therapeutic is appropriate for the patient. This includes reviewing the patient's medical history, confirming the clinical indication for the therapy, and ensuring there are no conflicts with other treatments the patient may be receiving.
This verification step helps maintain the same level of clinical oversight that patients expect when receiving traditional medications.
Benefits Investigation and Access Support
One of the most significant ongoing challenges with digital therapeutics is reimbursement and insurance coverage. Because DTx is still a relatively nascent category in healthcare — and commercial payers, Medicare, and Medicaid are still developing consistent coverage frameworks — coverage policies vary widely across plans, and gaps remain common. Pharmacies support a benefits investigation (BI) process to determine whether a digital therapeutic is covered and to help navigate prior authorization requirements. Managing these steps well is genuinely hard and requires expertise; when done right, it can meaningfully reduce delays and improve a patient's time to therapy.
Dispensing the Digital Therapeutic
Once the prescription has been verified and coverage confirmed, the pharmacy facilitates access to the digital therapeutic. Unlike traditional medications, this may not involve dispensing a physical product. Depending on the DTx manufacturer's commercialization model — some route access through hub services, some distribute directly — the pharmacy may provide the patient with secure access credentials, activation instructions, or a link to download the therapy through a partner application or web platform.
Ensuring this activation process is simple and seamless is critical to ensuring patients actually begin their therapy.
Patient Education and Onboarding
Patient engagement is one of the most important factors in the success of digital therapeutics. Pharmacies play a key role in helping patients understand how to access and use the therapy. This may include guiding patients through the activation process, providing onboarding materials, or demonstrating how to navigate the platform on their device.
Clear education at this stage helps reduce friction and improves the likelihood that patients remain engaged with their treatment.
Delivering a Seamless Patient Experience
Digital therapeutics are built around the promise of convenience and accessibility. However, that promise can quickly break down if the patient journey is fragmented or confusing — a real risk given how new the infrastructure supporting DTx still is.
Pharmacies can help deliver a smooth digital experience by integrating prescription verification, activation, and patient support into a cohesive workflow. A well-designed pharmacy experience ensures patients move easily from prescription to therapy without unnecessary barriers.
Monitoring Patient Progress
In some cases, pharmacies may also play a role in monitoring patient progress and engagement with the digital therapeutic. Because many DTx platforms generate real-time data, there is a meaningful opportunity for pharmacists to review patient activity or outcomes and collaborate with healthcare providers to ensure the therapy is working as intended — though realizing this potential depends on deeper integration between pharmacy workflows and DTx platforms, which the industry is still actively building toward.
This creates new opportunities for more continuous and proactive care management.
Billing and Reimbursement
Finally, pharmacies support the financial side of digital therapeutics by managing billing and reimbursement processes. This may involve submitting claims to insurance providers or working directly with patients on affordability solutions.
Handling these administrative processes helps ensure patients can access the therapies they need without unnecessary complexity.
The Future of Digital Therapeutics and Pharmacy
The DTx space has faced real growing pains — including high-profile commercial setbacks that underscore how difficult it is to bring these products to market without the right operational partners. Building a commercialization infrastructure that spans prescription verification, access, benefits investigation, patient education, and reimbursement is not a simple lift. Pharmacies that can execute across this full spectrum are rare, and their role is becoming more valuable, not less, as clinical validation for DTx products continues to grow.
As digital therapeutics continue to gain traction, pharmacies will play an increasingly important role in bringing these therapies to patients. By supporting prescription verification, access, education, and patient engagement, pharmacies act as a critical bridge between innovative digital treatments and real-world patient outcomes.
The continued evolution of digital healthcare will require infrastructure that can support both traditional medications and software-based therapies. Pharmacies that have built this capability are uniquely positioned to help power this transformation — and to ensure patients can benefit from the next generation of therapeutic innovation.
